KOREA WHO

Kim Jae-seob is the CEO of Aprogen and also serves as the co-CEO of Aprogen Biologics.

He was born on January 31, 1963, in Wonju, Gangwon-do.

Kim graduated from the Department of Microbiology at Seoul National University and earned his Ph.D. in Science from Seoul National University Graduate School.

He has held positions as a researcher at Cornell University, a research assistant professor at the University of Wisconsin, a professor at Seoul National University's Genetic Engineering Research Institute, and a professor at KAIST's Department of Biological Sciences.

In 2000, Kim founded the venture company Genexel. After acquiring Aprogen in 2006, he expanded the company aggressively through mergers and acquisitions, growing its affiliates to more than 10. During this process, the company diversified its business areas to include pharmaceutical distribution, gaming, and healthcare.

In October 2005, while serving as a professor at KAIST’s Department of Biological Sciences, Kim left a significant mark in academia by discovering a new biological clock gene, which he named "Han."

Thirteen years after acquiring Aprogen, he successfully transformed it into a unicorn company, a privately held venture company with a valuation exceeding KRW 1 trillion (approximately USD 721 million).

#KimJaeseob #Aprogen #CEO #Biotechnology #KAIST #SeoulNationalUniversity #BiologicalClockGene #UnicornCompany #Genexel #HealthcareIndustry